Zhang, C., Li, J., Wang, L., Ma, J., Li, X., Wu, Y., . . . Yang, Y. (2024). Terazosin, a repurposed GPR119 agonist, ameliorates mitophagy and β‐cell function in NAFPD by inhibiting MST1‐Foxo3a signalling pathway. Wiley. https://doi.org/10.1111/cpr.13764
Chicago Style (17th ed.) CitationZhang, Chenglei, et al. Terazosin, a Repurposed GPR119 Agonist, Ameliorates Mitophagy and β‐cell Function in NAFPD by Inhibiting MST1‐Foxo3a Signalling Pathway. Wiley, 2024. https://doi.org/10.1111/cpr.13764.
MLA (9th ed.) CitationZhang, Chenglei, et al. Terazosin, a Repurposed GPR119 Agonist, Ameliorates Mitophagy and β‐cell Function in NAFPD by Inhibiting MST1‐Foxo3a Signalling Pathway. Wiley, 2024. https://doi.org/10.1111/cpr.13764.
Warning: These citations may not always be 100% accurate.